Can withdrawal from Suboxone (buprenorphine/naloxone) occur after 2 days of treatment at 24mg/day?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Withdrawal After Brief Suboxone Exposure

Yes, you can experience withdrawal symptoms after stopping Suboxone following just 2 days of treatment at 24mg/day, though the severity will be significantly less than withdrawal from full opioid agonists due to buprenorphine's unique pharmacology.

Understanding Buprenorphine's Physical Dependence Profile

Buprenorphine causes physical dependence, but this develops more gradually than with full opioid agonists due to its partial agonist properties and slow dissociation from mu-opioid receptors 1, 2. Physical dependence may not occur to a clinically significant degree until after several days to weeks of continued use 1.

After only 2 days of exposure at 24mg/day, you are in a critical window where some physical dependence has likely begun but is not yet fully established 1, 2.

Expected Withdrawal Symptoms

If withdrawal occurs after this brief exposure, symptoms would likely include 1:

  • Mild to moderate symptoms: restlessness, anxiety, irritability
  • Physical symptoms: lacrimation (tearing), rhinorrhea (runny nose), perspiration, chills
  • Gastrointestinal effects: abdominal cramps, nausea, possible diarrhea
  • Sleep disturbances: insomnia
  • Musculoskeletal: myalgia (muscle aches), backache, joint pain

The severity after only 2 days would be substantially less than withdrawal after weeks or months of treatment 2.

Critical Pharmacologic Considerations

At 24mg/day, buprenorphine occupies approximately 95% of mu-opioid receptors 3. After 2 days of this high receptor occupancy, abrupt cessation will cause some degree of receptor adaptation, but the slow dissociation kinetics of buprenorphine mean withdrawal onset will be delayed (typically 24-72 hours after last dose) and protracted compared to short-acting full agonists 2.

Buprenorphine should not be abruptly discontinued in a physically-dependent patient; gradual dose reduction is recommended over rapid reduction or abrupt cessation 1, 2.

Recommended Approach for Discontinuation

Rather than abrupt cessation after 2 days at 24mg/day:

  • Taper the dose rapidly over 3-5 days (e.g., 16mg day 3, 8mg day 4, 4mg day 5, then stop) to minimize withdrawal symptoms 2
  • Monitor using Clinical Opiate Withdrawal Scale (COWS) - significant withdrawal is defined as 6+ point increase within 60 minutes 3
  • Provide supportive care including hydration, anti-diarrheals, NSAIDs for myalgias, and sleep aids if needed 3

Critical Safety Warning

The highest risk period is not the withdrawal itself, but the return to opioid use after discontinuation 4. If the reason for stopping Suboxone is to return to full opioid agonist use, understand that:

  • Tolerance to respiratory depression decreases rapidly
  • Risk of fatal overdose is markedly elevated after buprenorphine discontinuation 4
  • Patients who discontinue treatment have mortality rates of 1.82 per 100 person-years 4

Common Pitfall to Avoid

Do not confuse the ability to stop after 2 days with the appropriateness of stopping. If Suboxone was initiated for opioid use disorder treatment, discontinuing after only 2 days represents premature treatment termination and significantly increases overdose risk 5, 4. The standard induction protocol targets 16mg on day 1 with maintenance treatment, not brief exposure 5.

References

Research

Buprenorphine: how to use it right.

Drug and alcohol dependence, 2003

Guideline

Reducing Suboxone Dosage

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Buprenorphine/Naloxone Initiation Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.